CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells

Biological Chemistry

Volumn 383, Issue 7-8, 2002, Pages 1305-1308

  Montaser, Metwally ^a   Lalmanach, Gilles ^a   Mach, Lukas ^a  

^a Unviversitat fur Bodenkultur Wien   (Austria)

Author keywords

Cathepsin L; Cysteine proteinase; Lysosome; Proteinase inhibitor

Indexed keywords

[ 3 TRANS (PROPYLCARBAMOYL)OXIRANE 2 CARBONYL] ISOLEUCYL PROLINE; CATHEPSIN B; CATHEPSIN L; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; ESTER DERIVATIVE; METHYL GROUP; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; UNCLASSIFIED DRUG; CA 074 METHYL ESTER; CATHEPSIN; DIPEPTIDE; N (3 PROPYLCARBAMOYLOXIRANE 2 CARBONYL) ISOLEUCYL PROLINE; N-(3-PROPYLCARBAMOYLOXIRANE-2-CARBONYL)-ISOLEUCYL-PROLINE; PROTEINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME INHIBITION; EXPOSURE; FIBROBLAST; IN VIVO STUDY; LYSOSOME; MOUSE; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; ANIMAL; DRUG ANTAGONISM; ENZYMOLOGY;

ANIMALIA; MURINAE;

ANIMALS; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; DIPEPTIDES; FIBROBLASTS; MICE; PROTEASE INHIBITORS;

EID: 0036661078     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2002.147     Document Type: Article

References (24)

1. Authier, F., Méthoui, M., Bell, A.W., and Mort, J.S. (1999). Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B. J. Biol. Chem. 274, 33723-33731.
2. Bogyo, M., Verhelst, S., Bellingard-Dubouchaud, V., Toba, S., and Greenbaum, D. (2000). Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. Chem. Biol. 7, 27-38.
3. Buttle, D.J., Murata, M., Knight, C.G., and Barrett, A.J. (1992). CA074 methyl ester: a proinhibitor for intracellular cathepsin B. Arch. Biochem. Biophys. 299, 377-380.
4. Buttle, D.J., Handley, C.J., Ilic, M.Z., Saklatvala, J., Murata, M., and Barrett, A.J. (1993). Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metal loproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum. 36, 1709-1717.
5. Coulibaly, S., Schwihla, H., Abrahamson, M., Albini, A., Cerni, C., Clark, J.L., Ng, K.M., Katunuma, N., Schlappack, O., Glössl, J., and Mach, L. (1999). Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int. J. Cancer 83, 526-531.
6. Creemers, L.B., Hoeben, K.A., Jansen, D.C., Buttle, D.J., Beertsen, W., and Everts, V. (1998). Participation of intracellular cysteine proteinases, in particular cathepsin B, in degradation of collagen in periosteal tissue explants. Matrix Biol. 16, 575-584.
7. Foghsgaard, L., Wissing, D., Mauch, D., Lademann, U., Bastholm, L., Boes, M., Elling, F., Leist, M., and Jäättelä, M. (2001). Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153, 999-1009.
8. Guicciardi, M.E., Deussing, J., Miyoshi, H., Bronk, S.F., Svingen, P.A., Peters, C., Kaufmann, S.H., and Gores, G.J. (2000). Cathepsin B contributes to TNFα-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106, 1127-1137.
9. Halangk, W., Lerch, M.M., Brandt-Nedelev, B., Roth, W., Ruthenbuerger, M., Reinheckel, T., Domschke, W., Lippert, H., Peters, C., and Deussing, J. (2000). Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Invest. 106, 773-781.
10. Hashimoto, Y., Kagekawa, H., Narita, Y., Hachiya, Y., Hayakawa, T., Kos, J., Turk, V., and Katunuma, N. (2001). Significance of cathepsin B accumulation in synovial fluid of rheumatoid arthritis. Biochem. Biophys. Res. Commun. 283, 334-339.
11. Lalmanach, G., Mayer, R., Serveau, C., Scharfstein, J., and Gauthier, F. (1996). Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi. Biochem. J. 318, 395-399.
12. Lorenzo, K., Ton, P., Clark, J.L., Coulibaly, S., and Mach, L. (2000). Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor. Cancer Res. 60, 4070-4076.
13. Murata, M., Miyashita, S., Yokoo, C., Tamai, M., Hanada, K., Hatayama, K., Towatari, T., Nikawa, T., and Katunuma, N. (1991). Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. FEBS Lett. 280, 307-310.
14. Navab, R., Chevet, E., Authier, F., Di Guglielmo, G.M., Bergeron, J.J., and Brodt, P. (2001). Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions. J. Biol. Chem. 276, 13644-13649.
15. Okamura-Oho, Y., Zhang, S., Callahan, J.W., Murata, M., Oshima, A., and Suzuki, Y. (1997). Maturation and degradation of β-galactosidase in the post-Golgi compartment are regulated by cathepsin B and a non-cysteine proteinase. FEBS Lett. 419, 231-234.
16. Riese, R.J., and Chapman, H.A. (2000). Cathepsins and compartmentalization in antigen presentation. Curr. Opin. Immunol. 12, 107-113.
17. Roberts, L.R., Kurosawa, H., Bronk, S.F., Fesmier, R.J., Agellon, L.B., Leung, W.-Y, Mao, F., and Gores, G.J. (1997). Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 113, 1714-1726.
18. Roth, W., Deussing, J., Botchkarev, V.A., Pauly-Evers, M., Saftig, R., Hafner, A., Schmidt, P., Schmahl, W., Scherer, J., Anton-Lamprecht, I., von Figura, K., Paus, R., and Peters, C. (2000). Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and perturbation of hair follicle cycling. FASEB J. 14, 2075-2086.
19. Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J.D., Schu, R., and von Figura, K. (1998). Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K-deficient mice. Proc. Natl. Acad. Sci. USA 95, 13453-13458.
20. Spizz, G., and Blackshear, R.J. (1997). Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme. J. Biol. Chem. 272, 23833-23842.
21. Szpaderska, A.M., and Frankfater, A. (2001). An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res. 61, 3493-3500.
22. Turk, B., Turk, D., and Turk, V. (2000). Lysosomal cysteine proteinases: more than scavengers. Biochim. Biophys. Acta 1477, 98-111.
23. Turk, D., Podobnik, M., Popovic, T., Katunuma, N., Bode, W., Huber, R., and Turk, V. (1995). Crystal structure of cathepsin B inhibited with CA030 at 2.0 Å resolution: a basis for the design of specific epoxysuccinyl inhibitors. Biochemistry 34, 4791-4797.
24. Walker, B., Cullen, B.M., Kay, G., Halliday, I.M., McGinty, A., and Nelson, J. (1992). The synthesis, kinetic characterisation and application of a novel biotinylated affinity label of cathepsin B. Biochem. J. 283, 449-453.